EUVIMEDEUVIMED entdecken
Historischer BeitragOpen Access

Self-Managed Medication Abortion: History, Evidence, Models of Care, and Policy Considerations

Laura E Jacobson iD, Caitlin Gerdts

American Journal of Public Health · 2025

DOI: 10.2105/ajph.2025.308133 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift American Journal of Public Health, 2025. Verfasst von Laura E Jacobson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laura E. Jacobson is with the Oregon Health & Science University-Portland State University School of Public Health, Portland. Caitlin Gerdts is with …. Hauptthemen laut MEDLINE: Abortion, Induced, Health Policy, Self-Management. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Self-managed abortion (SMA) represents a significant shift in the abortion landscape, offering an alternative to facility-based care via the medication misoprostol with or without mifepristone. The World Health Organization recommends SMA with medications as safe and effective up to 12 weeks’ gestation and with access to information and health system referrals. Increasing prevalence of SMA can be attributed to a range of factors, including legal and logistical barriers to facility-based care as well as a social movement advocating autonomy and demedicalized practices in the United States, particularly after the US Supreme Court decided Dobbs v Jackson Women’s Health Org., 597 US (2022). We document the history, safety and effectiveness, measurement challenges, and models of SMA care and review ongoing legal and policy challenges. Despite its clinical and practical advantages, SMA exists in a complex policy environment that hinders access to safe abortion. Evidence from diverse regions demonstrates the potential for SMA to expand access, especially where care is limited or restricted. As research affirms the safety of SMA, including later in pregnancy, it remains vital to protect and expand access to abortion medications, without threat of criminalization, to ensure that individuals can exercise their reproductive rights and autonomy. ( Am J Public Health. 2025;115(10):1734–1741. https://doi.org/10.2105/AJPH.2025.308133 )

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortion, InducedHealth PolicySelf-ManagementHumansFemalePregnancyUnited StatesMisoprostolHealth Services AccessibilityMifepristoneHistory, 20th CenturyHistory, 21st Century

Substanzen

MisoprostolMifepristone

Autor:innen und Institutionen

  • Laura E. Jacobson is with the Oregon Health & Science University-Portland State University School of Public Health, Portland. Caitlin Gerdts is with Ibis Reproductive Health, Oakland, CA.

ORCID-Profile: Laura E Jacobson

Zitieren

APA

Jacobson, L. E., & Gerdts, C. (2025). Self-Managed Medication Abortion: History, Evidence, Models of Care, and Policy Considerations. American Journal of Public Health. https://doi.org/10.2105/ajph.2025.308133

Vancouver

Jacobson LE, Gerdts C. Self-Managed Medication Abortion: History, Evidence, Models of Care, and Policy Considerations. American Journal of Public Health. 2025. doi:10.2105/ajph.2025.308133

BibTeX
@article{Jacobson2025,
  author = {Jacobson, Laura E and Gerdts, Caitlin},
  title = {Self-Managed Medication Abortion: History, Evidence, Models of Care, and Policy Considerations},
  journal = {American Journal of Public Health},
  year = {2025},
  doi = {10.2105/ajph.2025.308133}
}
Kostenlos starten →